10-day decitabine with venetoclax for newly diagnosed intensive chemotherapy ineligible, and relapsed or refractory acute myeloid leukaemia: a single-centre, phase 2 trial Redazione 10 Settembre 2020 ...
Outcomes of COVID-19 in patients with CLL: a multicenter international experience Redazione 10 Settembre 2020 ...
Ponatinib coronary microangiopathy: novel bedside diagnostic approach and management with N-acetylcysteine Redazione 10 Settembre 2020 ...
US Food and Drug Administration approvals for Bruton tyrosine kinase inhibitors in patients with chronic lymphocytic leukemia: Potential inefficiencies in trial design and evidence generation Redazione 10 Settembre 2020 ...
Lisocabtagene maraleucel for patients with relapsed or refractory large B-cell lymphomas (TRANSCEND NHL 001): a multicentre seamless design study Redazione 10 Settembre 2020 ...
Practical guidance for the management of acute lymphoblastic leukemia in the adolescent and young adult population Redazione 3 Settembre 2020 ...
Characterization of FLT3-ITDmut acute myeloid leukemia: molecular profiling of leukemic precursor cells Redazione 3 Settembre 2020 ...
Venetoclax plus obinutuzumab versus chlorambucil plus obinutuzumab for previously untreated chronic lymphocytic leukaemia (CLL14): follow-up results from a multicentre, open-label, randomised, phase 3 trial Redazione 3 Settembre 2020 ...
Sorafenib maintenance in patients with FLT3-ITD acute myeloid leukaemia undergoing allogeneic haematopoietic stem-cell transplantation: an open-label, multicentre, randomised phase 3 trial Tisagenlecleucel in Adult Relapsed or Refractory Diffuse Large B-Cell Lymphoma Redazione 3 Settembre 2020 ...
